SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (256)10/10/2001 7:50:43 PM
From: Extra Pale  Read Replies (2) of 724
 
Rick,
Based on 2nd quarter results, next 12months
Revenue = $60m
COGS = 36
SG&A = 16
R&D = 3

Net Operating Income = $5m or $.74/share
assuming NOI = NI, at a pe of 15x per share value = $11
at pe of 20x per share value = $14.8

At current four bucks a share I am comfortable with risk reward ratio no matter how old management is (tho I too wish they would quit selling shares for pocket change!)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News